SCOPUS
Pharmaceutical Science Advances
Elsevier, Netherlands
Pharmaceutical Science Advances is an academic journal published by Elsevier (Netherlands). Identifiers: eISSN 2773-2169. Indexed in SCOPUS. Metrics: CiteScore 2.3, SJR 0.379, SNIP 0.57. tlooto lists 161 papers from this journal.
CiteScore
2.30
Scopus citation metric
SJR
0.379
SCImago rank
SNIP
0.57
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2773-2169
- Abbreviation
- -
- Publisher
- Elsevier
- Country
- Netherlands
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
3001 Pharmacology3003 Pharmaceutical Science3004 Pharmacology
Papers in this journal
Recent papers
- Discovery of novel Kir4.1 inhibitors based on serdemetan with potential therapy for glioblastoma-depression comorbidity
2026
- Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation
2026 · 2 citations
- BGC1201: A potent allosteric SHP2 inhibitor with broad antitumor activity in lung, pancreatic, and esophageal cancer xenografts
2026
- Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib
2026
- Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery.
2026
Most cited papers
- The effect of particle size on drug bioavailability in various parts of the body
2023 · 107 citations
- Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management
2023 · 41 citations
- Natural product databases for drug discovery: Features and applications
2024 · 34 citations
- Targeted drug conjugates in cancer therapy: Challenges and opportunities
2024 · 32 citations
- Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies
2023 · 27 citations